How does endothelial cell injury start? The role of endothelin in systemic sclerosis

Arthritis Research and Therapy

Volumn 9, Issue SUPPL. 2, 2007, Pages

  Abraham, David ^a   Distler, Oliver ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ENDOTHELIAL CELL ANTIBODY; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR;

DISEASE COURSE; DISEASE PREDISPOSITION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM INJURY; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; HYPOXIA; INFECTION; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PERICYTE; PLEIOTROPY; PROTEIN FUNCTION; REVIEW; SYSTEMIC SCLEROSIS; TISSUE INJURY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; ANIMAL; ENDOTHELIUM CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELINS; HUMANS; SCLERODERMA, SYSTEMIC;

EID: 35349019900     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2186     Document Type: Review

References (32)

1. Koch AE Distler O Vasculopathy and disordered angiogenesis in selected rheumatic diseases: Rheumatoid arthritis and systemic sclerosis Arthritis Res Ther 2007 9 Suppl 2 S3
2. Ross R Atherosclerosis: An inflammatory disease N Engl J Med 1999 340 115-126 10.1056/NEJM199901143400207 9887164
3. Newby AC Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates Cardiovasc Res 2006 69 614-624 10.1016/ j.cardiores.2005.08.002 16266693
4. Bou-Gharios G Ponticos M Rajkumar V Abraham D Extra-cellular matrix in vascular networks Cell Prolif 2004 37 207-220 10.1111/ j.1365-2184.2004.00306.x 15144498
5. Denton CP Black CM Abraham DJ Mechanisms and consequences of fibrosis in systemic sclerosis Nat Clin Pract Rheumatol 2006 2 134-144 10.1038/ ncprheum0115 16932673
6. Abraham DJ Varga J Scleroderma: From cell and molecular mechanisms to disease models Trends Immunol 2005 26 587-595 10.1016/j.it.2005.09.004 16168711
7. Jimenez SA Derk CT Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis Ann Intern Med 2004 140 37-50 14706971
8. Chizzolini C Parel Y Scheja A Dayer JM Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts Arthritis Res Ther 2005 8 R10 10.1186/ar1860
9. Ihn H Scleroderma, fibroblasts, signaling, and excessive extracellular matrix Curr Rheumatol Rep 2005 7 156-162 10.1007/s11926-005-0069-9 15760596
10. Nguyen VA Sgonc R Dietrich H Wick G Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (scleroderma) J Autoimmun 2000 14 143-149 10.1006/jaut.1999.0355 10677245
11. Yamamoto T The bleomycin-induced scleroderma model: What have we learned for scleroderma pathogenesis? Arch Dermatol Res 2006 297 333-344 10.1007/ s00403-005-0635-z 16402183
12. Nagase H Visse R Murphy G Structure and function of matrix metalloproteinases and TIMPs Cardiovasc Res 2006 69 562-573 10.1016/ j.cardiores.2005.12.002 16405877
13. Carvalho D Savage CO Black CM Pearson JD IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines J Clin Invest 1996 97 111-119 507068 8550821
14. Ahmed SS Tan FK Arnett FC Jin L Geng YJ Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies Arthritis Rheum 2006 54 2250-2262 10.1002/art.21952 16802364
15. Baroni SS Santillo M Bevilacqua F Luchetti M Spadoni T Mancini M Fraticelli P Sambo P Funaro A Kazlauskas A et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis N Engl J Med 2006 354 2667-2676 10.1056/NEJMoa052955 16790699
16. Rubanyi GM Polokoff MA Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology Pharmacol Rev 1994 46 325-415 7831383
17. Galiè N Manes A Branzi A The endothelin system in pulmonary arterial hypertension Cardiovasc Res 2004 61 227-237 10.1016/ j.cardiores.2003.11.026 14736539
18. La M Reid JJ Endothelin-1 and the regulation of vascular tone Clin Exp Pharmacol Physiol 1995 22 315-323 10.1111/j.1440-1681.1995.tb02008.x 7554421
19. Fagan KA McMurtry IF Rodman DM Role of endothelin-1 in lung disease Respir Res 2001 2 90-101 59574 11686871 10.1186/rr44
20. Shimada K Matsushita Y Wakabayashi K Takahashi M Matsubara A Iijima Y Tanzawa K Cloning and functional expression of human endothelin-converting enzyme cDNA Biochem Biophys Res Commun 1995 207 807-812 10.1006/bbrc.1995.1258 7864876
21. Fernandez-Patron C Zouki C Whittal R Chan JS Davidge ST Filep JG Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32] FASEB J 2001 15 2230-2240 10.1096/ fj.01-0178com 11641250
22. Wilson SH Simari RD Lerman A The effect of endothelin-1 on nuclear factor kappa B in macrophages Biochem Biophys Res Commun 2001 286 968-972 10.1006/bbrc.2001.5485 11527395
23. Vancheeswaran R Magoulas T Efrat G Wheeler-Jones C Olsen I Penny R Black CM Circulating endothelin-1 levels in systemic sclerosis subsets: A marker of fibrosis or vascular dysfunction? J Rheumatol 1994 21 1838-1844 7837147
24. Abraham DJ Vancheeswaran R Dashwood MR Rajkumar VS Pantelides P Xu SW du Bois RM Black CM Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease Am J Pathol 1997 151 831-841 1857854 9284832
25. Shi-Wen X Denton CP Dashwood MR Holmes AM Bou-Gharios G Pearson JD Black CM Abraham DJ Fibroblast matrix gene expression and connective tissue remodeling: Role of endothelin-1 J Invest Dermatol 2001 116 417-425 10.1046/j.1523-1747.2001.01256.x 11231316
26. Shi-Wen X Chen Y Denton CP Eastwood M Renzoni EA Bou-Gharios G Pearson JD Dashwood M du Bois RM Black CM et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/ phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts Mol Biol Cell 2004 15 2707-2719 420095 15047866 10.1091/mbc.E03-12-0902
27. Koch AE Kronfeld-Harrington LB Szekanecz Z Cho MM Haines GK Harlow LA Strieter RM Kunkel SL Massa MC Barr WG et al. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease Pathobiology 1993 61 239-246 7507681
28. Sakkas LI Chikanza IC Platsoucas CD Mechanisms of disease: The role of immune cells in the pathogenesis of systemic sclerosis Nat Clin Pract Rheumatol 2006 2 679-685 10.1038/ncprheum0346 17133253
29. Abraham C Griffith J Miller J The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand J Immunol 1999 162 4399-4405 10201975
30. Waters CE Shi-Wen X Denton CP Abraham DJ Pearson JD Signaling pathways regulating intercellular adhesion molecule 1 expression by endothelin 1: comparison with interleukin-1beta in normal and scleroderma dermal fibroblasts Arthritis Rheum 2006 54 649-660 10.1002/art.21572 16447227
31. Xu SW Denton CP Dashwood MR Abraham DJ Black CM Endothelin-1 regulation of intercellular adhesion molecule-1 expression in normal and sclerodermal fibroblasts J Cardiovasc Pharmacol 1998 Suppl 1 S545-S547 10.1097/00005344-199800001-00157
32. Sgonc R Gruschwitz MS Dietrich H Recheis H Gershwin ME Wick G Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma J Clin Invest 1996 98 785-792 507489 8698871